Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Extended-Release Once-Daily SPN-538 (Trokendi XR™) vs. Twice-Daily TPM-IR (Topamax®): Impact of Dosing Irregularities on Topiramate Concentrations
Epilepsy/Clinical Neurophysiology (EEG)
(-)
259
Authors/Disclosures
Scott Brittain (Supernus Pharmaceuticals, Inc.)
PRESENTER 		No disclosure on file
Fernando F. Figueira, MD No disclosure on file